ArticleClinical and experimental medicine2026
Reducing false positives in breast cancer screening with computer-aided detection.
Article in Clinical and experimental medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The development of an advanced computer-aided detection (CAD) system for breast cancer detection is essential to improving diagnostic accuracy and reducing unnecessary interventions. This study introduces a multi-dimensional CAD system that combines Mask R-CNN, dual-view mammography (CC/MLO), and nipple localization techniques to enhance the detection of breast tumors while minimizing false positive rates (FPR). A retrospective study involving 226 mammograms from 113 patients with 234 pathologically confirmed tumors was performed. Image preprocessing included DICOM-to-PNG conversion, orientation correction, and background removal, followed by Mask R-CNN processing. The system incorporated dual-view spatial consistency checks to align views from CC and MLO projections, nipple localization using Sauvola thresholding and Laplacian filtering, and optimization of the tumor-to-nipple distance for improved accuracy. Evaluation metrics (precision, recall, F1-score, FPR, FNR) were analyzed, and statistical significance was assessed using chi-square tests. The results showed a significant 87.3% reduction in FPR (8.26% vs. 38.46%, p < 0.001) and an increase in precision (91.74% vs. 61.54%). The recall slightly decreased, but the F1-score showed a balanced improvement. These findings demonstrate the potential of this advanced CAD system to support high-specificity breast cancer screening and improve clinical decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.